glp-1/gip agonists Schematic illustration of monoagonists, dual and triple GLP-1 agonists approved for clinical

Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made

Koole, C., Savage, E

And medication should be used temporarily and sparingly whenever possible

doi: 10.1007/s11695-021-05394-x [DOI] [PubMed] [Google Scholar] 20.Voorwinde V, Hoekstra T, Monpellier VM, Steenhuis IHM, Janssen IMC, van Stralen MM

Kelly and Sipos 2024)

Srivastava, G